Background. Blood cultures (BC) fail to detect a pathogen in most patients with neutropenic fever (NF). We examined the performance of the Karius next generation sequencing plasma test (plasma NGS) compared with that of BC in chemotherapy-induced NF.
Background. Skin and soft-tissue infections can manifest in a variety of ways, ranging from a self-resolving abscess to a rapidly spreading necrotizing soft-tissue infection (NSTI). Based on culture data, the microbiology of both infections are similar, both involving Gram-positive cocci such as Staphylococcus species. This begs the question -why would different patients start with seemingly similar infections and end with drastically different clinical courses? One factor is the patient's immune response, but it does not fully account for many NSTIs that occur in otherwise healthy individuals. We hypothesize that anaerobes, which are difficult to detect via culture and thus are under-detected, worsen the infection, favoring the NSTI pathology. Our objective in this study was to better understand the impact of anaerobes in NSTIs.
Methods. We enrolled adult patients that had been diagnosed either with NSTIs or abscesses. We collected samples of their infections via routine skin debridements or incision and drains, respectively. We then extracted DNA from each sample and sequenced the variable regions 1-2 of the 16S rRNA. The sequences were compared against an in house database and for species identification.
Results. From December 2011 to the present, we have collected 26 NSTI samples and 19 abscess samples. We found that a higher proportion of obligate anaerobes in the wound is correlated with increased BMI and mortality in NSTIs. The wound microbiomes of patients who died from their infections also seem to cluster together. Moreover, our preliminary data suggest that NSTIs may also have a higher proportion of obligate anaerobes and higher microbial diversity compared with abscess infections. Lastly, we noted significant disconcordance between data obtained by our institution clinical microbiology laboratory and our 16S data.
Conclusion. The presence of obligate anaerobes, traditionally difficult to detect via culture, plays a significant role in the development and worsened clinical outcome of NSTIs. Their presence may be one of the determining factors that favor the NSTI pathology over the easily-treated abscess. If true, this should lead to more aggressive and comprehensive anaerobe coverage in NSTIs, especially in culture-negative infections.
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Evaluation of a Multiplex PCR Assay with Molecular Beacon Probes to Rapidly Detect Bacterial Pathogens Directly in Bronchial Alveolar Lavage (BAL) Samples from Patients with Hospital-Acquired Pneumonia (HAP)
Kalyan D. Background. Bacterial pneumonia is a common complication in hospitalized patients and it is associated with high morbidity and mortality. Standard culture-based methods may take 2-3 days to identify the etiologies of HAP, leading to delays in appropriate therapy. A rapid molecular assay that could diagnose the etiology of bacterial pneumonia directly from BAL samples within a few hours could facilitate faster and more directed administration of antimicrobial therapy.
Methods. BAL samples were collected from hospitalized patients with suspected pneumonia, including ventilated patients, from December 2016 through April 2017. Genomic DNA was isolated from BAL samples using NucliSENS Results. We evaluated 53 BAL samples to identify the bacterial pathogen and key resistance determinants. Thirty-one samples yielded growth of ≥1 × 10 4 CFU/mL of bacteria by quantitative culture. The bacterial identification using MB-PCR for 16S rRNA correctly identified the presence of bacteria in all 31 samples (100% sensitivity). The MB-PCR identified P. aeruginosa (n = 5), S. aureus (n = 5), E. coli (n = 1), A. baumannii (n = 1), and K. pneumoniae (n = 1) in BAL samples that yielded ≥1 × 10 4 CFU/ mL of the same pathogen by culture (100% sensitivity). The MB-PCR also identified bla TEM -harboring E. coli that grew ampicillin-resistant E. coli by culture. The specificity of the16S rRNA probe was 70%, as 7/53 BAL were false positive, whereas the specificity for the MB-PCR was 100% for P. aeruginosa, S. aureus, E. coli, and A. baumannii, and 98% for K. pneumoniae.
Conclusion. Multiplex MB-PCR assay is a rapid, sensitive and specific tool for detection of common bacterial causes of nosocomial pneumonia and important resistance determinants directly from BAL samples. Saturday, October 7, 2017: 12:30 PM Background. Babesiosis is a tick-borne infection of erythrocytes caused by parasites of the genus Babesia. In United States most of the reported cases occur in the Northeast and upper Midwestern states, New York being an endemic area. Majority of the cases in the United States is due to infection with Babesia microti. Most patients with babesiosis are asymptomatic or have a mild illness, but some may develop fatal illness. Current laboratory diagnosis of Babesiosis including parasitemia is by microscopic demonstration of intraerythrocytic Babesia parasites in blood films which requires specially trained personnel. We have developed a simple and rapid PCR assay for the detection of B. microti 18S rRNA gene (BMPCR) which can be used as an alternative screening assay.
Methods. BMPCR assay was developed based on Luminex Multicode technology using Luminex Aries instrument and in-house developed primers. Babesia positive clinical samples confirmed by NY State Department of Health and clinical samples negative for Babesia were used to determine accuracy. Specificity was evaluated using malaria positive samples, several bacterial isolates, selected B. microti strains and other Babesia species. Limit of Detection was determined using known copies of B. microti DNA. Reproducibility of the assay was assessed by testing samples on different days and runs by different analysts.
Results. Accuracy of the BMPCR assay was 100% for the 30 Babesia positive and 30 negative samples. All B. microti ATCC strains were positive by BMPCR. 95% LOD of the assay as determined by probit analysis was 1177 copies/50µl of blood. Sensitivity of the assay was higher than that of microscopic detection and specificity was 100%.
